vs
Side-by-side financial comparison of EGAIN Corp (EGAN) and Laird Superfood, Inc. (LSF). Click either name above to swap in a different company.
EGAIN Corp is the larger business by last-quarter revenue ($23.0M vs $13.3M, roughly 1.7× Laird Superfood, Inc.). EGAIN Corp runs the higher net margin — 10.2% vs -13.2%, a 23.3% gap on every dollar of revenue. On growth, Laird Superfood, Inc. posted the faster year-over-year revenue change (15.0% vs 2.6%). Over the past eight quarters, Laird Superfood, Inc.'s revenue compounded faster (16.1% CAGR vs 1.4%).
Headquartered in Sunnyvale, California, eGain Corporation helps businesses automate customer and employee experience with its AI knowledge software.
Laird Superfood, Inc. develops, manufactures and sells a portfolio of plant-based functional superfood products, including premium coffee creamers, hydration blends, nutritional supplements, and plant-powered snacks. It serves health-conscious consumers through direct-to-consumer e-commerce platforms and offline retail partners, mainly operating in the North American market with a focus on sustainably sourced clean ingredients.
EGAN vs LSF — Head-to-Head
Income Statement — Q2 FY2026 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $23.0M | $13.3M |
| Net Profit | $2.3M | $-1.8M |
| Gross Margin | 73.1% | 34.1% |
| Operating Margin | 8.9% | -13.5% |
| Net Margin | 10.2% | -13.2% |
| Revenue YoY | 2.6% | 15.0% |
| Net Profit YoY | 248.1% | -341.4% |
| EPS (diluted) | $0.08 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $23.0M | $13.3M | ||
| Q3 25 | $23.5M | $12.9M | ||
| Q2 25 | $23.2M | $12.0M | ||
| Q1 25 | $21.0M | $11.7M | ||
| Q4 24 | $22.4M | $11.6M | ||
| Q3 24 | $21.8M | $11.8M | ||
| Q2 24 | $22.5M | $10.0M | ||
| Q1 24 | $22.4M | $9.9M |
| Q4 25 | $2.3M | $-1.8M | ||
| Q3 25 | $2.8M | $-975.1K | ||
| Q2 25 | $30.9M | $-362.2K | ||
| Q1 25 | $66.0K | $-156.2K | ||
| Q4 24 | $671.0K | $-398.4K | ||
| Q3 24 | $652.0K | $-166.1K | ||
| Q2 24 | $1.5M | $-239.1K | ||
| Q1 24 | $1.5M | $-1.0M |
| Q4 25 | 73.1% | 34.1% | ||
| Q3 25 | 75.2% | 36.5% | ||
| Q2 25 | 72.7% | 39.9% | ||
| Q1 25 | 68.0% | 41.9% | ||
| Q4 24 | 70.2% | 38.6% | ||
| Q3 24 | 69.4% | 43.0% | ||
| Q2 24 | 69.3% | 41.8% | ||
| Q1 24 | 69.3% | 40.0% |
| Q4 25 | 8.9% | -13.5% | ||
| Q3 25 | 12.1% | -7.7% | ||
| Q2 25 | 14.0% | -3.3% | ||
| Q1 25 | 0.1% | -1.9% | ||
| Q4 24 | 2.9% | -4.1% | ||
| Q3 24 | 2.3% | -2.3% | ||
| Q2 24 | 5.3% | -3.4% | ||
| Q1 24 | 4.2% | -11.0% |
| Q4 25 | 10.2% | -13.2% | ||
| Q3 25 | 12.0% | -7.6% | ||
| Q2 25 | 132.8% | -3.0% | ||
| Q1 25 | 0.3% | -1.3% | ||
| Q4 24 | 3.0% | -3.4% | ||
| Q3 24 | 3.0% | -1.4% | ||
| Q2 24 | 6.7% | -2.4% | ||
| Q1 24 | 6.7% | -10.3% |
| Q4 25 | $0.08 | — | ||
| Q3 25 | $0.10 | — | ||
| Q2 25 | $1.09 | — | ||
| Q1 25 | $0.00 | — | ||
| Q4 24 | $0.02 | — | ||
| Q3 24 | $0.02 | — | ||
| Q2 24 | $0.05 | — | ||
| Q1 24 | $0.05 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $83.1M | $5.1M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $88.8M | $11.5M |
| Total Assets | $146.8M | $19.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $83.1M | $5.1M | ||
| Q3 25 | $70.9M | $5.1M | ||
| Q2 25 | $62.9M | $3.9M | ||
| Q1 25 | $68.7M | $7.0M | ||
| Q4 24 | $70.5M | $8.3M | ||
| Q3 24 | $67.2M | $7.9M | ||
| Q2 24 | $70.0M | $7.6M | ||
| Q1 24 | $83.0M | $7.1M |
| Q4 25 | $88.8M | $11.5M | ||
| Q3 25 | $83.5M | $12.8M | ||
| Q2 25 | $80.7M | $13.4M | ||
| Q1 25 | $51.6M | $13.3M | ||
| Q4 24 | $55.3M | $13.2M | ||
| Q3 24 | $55.7M | $13.1M | ||
| Q2 24 | $58.5M | $12.6M | ||
| Q1 24 | $63.9M | $12.7M |
| Q4 25 | $146.8M | $19.2M | ||
| Q3 25 | $144.6M | $18.9M | ||
| Q2 25 | $148.0M | $20.4M | ||
| Q1 25 | $106.2M | $21.5M | ||
| Q4 24 | $111.3M | $19.3M | ||
| Q3 24 | $114.9M | $18.8M | ||
| Q2 24 | $127.9M | $18.0M | ||
| Q1 24 | $120.3M | $17.6M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $10.1M | $68.4K |
| Free Cash FlowOCF − Capex | $9.9M | — |
| FCF MarginFCF / Revenue | 43.0% | — |
| Capex IntensityCapex / Revenue | 1.0% | — |
| Cash ConversionOCF / Net Profit | 4.33× | — |
| TTM Free Cash FlowTrailing 4 quarters | $17.6M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $10.1M | $68.4K | ||
| Q3 25 | $10.4M | $1.2M | ||
| Q2 25 | $-4.3M | $-2.8M | ||
| Q1 25 | $2.2M | $-1.3M | ||
| Q4 24 | $6.4M | $339.2K | ||
| Q3 24 | $954.0K | $305.8K | ||
| Q2 24 | $-5.1M | $642.7K | ||
| Q1 24 | $1.7M | $-422.3K |
| Q4 25 | $9.9M | — | ||
| Q3 25 | $10.2M | — | ||
| Q2 25 | $-4.5M | — | ||
| Q1 25 | $2.1M | — | ||
| Q4 24 | $6.3M | — | ||
| Q3 24 | $845.0K | — | ||
| Q2 24 | $-5.2M | — | ||
| Q1 24 | $1.7M | — |
| Q4 25 | 43.0% | — | ||
| Q3 25 | 43.4% | — | ||
| Q2 25 | -19.5% | — | ||
| Q1 25 | 10.0% | — | ||
| Q4 24 | 28.1% | — | ||
| Q3 24 | 3.9% | — | ||
| Q2 24 | -23.0% | — | ||
| Q1 24 | 7.8% | — |
| Q4 25 | 1.0% | — | ||
| Q3 25 | 1.0% | — | ||
| Q2 25 | 0.9% | — | ||
| Q1 25 | 0.5% | — | ||
| Q4 24 | 0.6% | — | ||
| Q3 24 | 0.5% | — | ||
| Q2 24 | 0.2% | — | ||
| Q1 24 | 0.1% | — |
| Q4 25 | 4.33× | — | ||
| Q3 25 | 3.70× | — | ||
| Q2 25 | -0.14× | — | ||
| Q1 25 | 33.48× | — | ||
| Q4 24 | 9.57× | — | ||
| Q3 24 | 1.46× | — | ||
| Q2 24 | -3.40× | — | ||
| Q1 24 | 1.17× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
EGAN
| Transferred Over Time | $22.0M | 96% |
| Technology Service | $1.2M | 5% |
LSF
| Wholesale | $7.0M | 52% |
| Coffee Tea And Hot Chocolate Products | $4.4M | 33% |
| Hydration And Beverage Enhancing Supplements | $1.6M | 12% |
| Other | $352.6K | 3% |
